companydata.dkcompanydata.dk

GXP-PHARMA SUPPORT ApS: Financial statements 2020

CVR: 36033347

Source: annual report 2020, Danish Business Authority

01/01/202031/12/2020

GXP-PHARMA SUPPORT ApS (CVR 36033347) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,000,079 and a net result of DKK 664,083 compared with DKK 328,406 the year before. That is a decrease of 14.4% compared with the year before. Equity in the 2020 report amounted to DKK 1,692,199. The solvency ratio was 42.6%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,000,079
Profit/Loss
DKK 664,083
Equity
DKK 1,692,199
Total Assets
DKK 3,975,606
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-1 mio.664 t.1.7 mio.1
2019-1.2 mio.328 t.1.4 mio.-
2018-1.5 mio.28 t.1.1 mio.-
2017-1.1 mio.424 t.1.9 mio.-
2016-1.5 mio.154 t.1.4 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is GXP-PHARMA SUPPORT ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

GXP-PHARMA SUPPORT ApS: The 2019 annual report is outMay 27, 2020

GXP-PHARMA SUPPORT ApS has published its annual report for 2019. Gross profit came to DKK 1,167,811, and the net result was DKK 328,406.

About GXP-PHARMA SUPPORT ApS

GXP-PHARMA SUPPORT ApS is a Danish company of the type Anpartsselskab based in Sorø, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The company was previously named GXP-PHARMA SUPPORT A/S. The management consists of Lone Cleveland Andersen. The company is owned by CHRIBEN ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 128,518 and a net result of DKK -314,498 compared with DKK -166,431 the year before. Equity in the 2025 report amounted to DKK 58,748.

Source: annual report 2025, Danish Business Authority